Last updated: February 15, 2026
Overview
NDC 10631-0003 is a proprietary medication marketed as an injectable corticosteroid, commonly used for inflammation, allergies, and certain autoimmune conditions. Its primary indications include rheumatoid arthritis, osteoarthritis, and dermatological disorders, with a broad prescribing footprint in outpatient and hospital settings.
Market Size and Demand
The demand for corticosteroids like NDC 10631-0003 is driven by the prevalence of autoimmune and inflammatory diseases. The global rheumatoid arthritis market alone is projected to reach $31.4 billion by 2027, growing at CAGR of 4.4% (Fortune Business Insights [1]). Corticosteroids account for a significant segment within this market, with approximately 20% of prescriptions for chronic inflammatory conditions involving steroid therapy.
In the United States, approximately 2.1 million Americans have rheumatoid arthritis, with corticosteroid use in around 25% of these cases. The hospital outpatient setting remains the largest revenue source, with increasing adoption due to its versatility and established efficacy.
Competitive Landscape
NDC 10631-0003 competes primarily with other injectable corticosteroids such as methylprednisolone, triamcinolone, and hydrocortisone formulations. Leading market players include Pfizer, Mylan, and Teva. The entry of biosimilars and generic versions has expanded competition, exerting downward pressure on pricing.
In 2021, the average wholesale price (AWP) for comparable corticosteroids ranged from $2.50 to $5.00 per vial, depending on dosage and brand. Generics typically retail at a 20-50% discount relative to branded options.
Pricing and Reimbursement Trends
Pricing dynamics are influenced by:
- Role of PBMs and insurance: Preferred formularies and insurance networks significantly impact net prices.
- Generic availability: As patents expire, generic versions reduce average prices.
- Healthcare policy: CMS and private insurers increasingly promote cost-effective treatments, pressuring manufacturers on list prices.
In 2022, the average sale price (ASP) for injectable corticosteroids fell approximately 10-15% compared to 2021, reflecting increased generic competition.
Price Projections
Based on historical data and current market trends:
| Year |
Estimated Price Range (per vial) |
Notes |
| 2023 |
$2.50 – $4.50 |
Anticipated stabilization, slight decrease due to ongoing generics entry. |
| 2024 |
$2.20 – $4.00 |
Slight further reduction expected, driven by generic competition. |
| 2025 |
$2.00 – $3.80 |
Continued downward trend, potential pressure from biosimilar entries. |
Projections assume no significant patent litigations or regulatory changes that could disrupt supply or pricing structures.
Key Market Drivers
- Increasing prevalence of autoimmune disorders.
- Expanding use of corticosteroids for various indications.
- Growth in outpatient administration settings.
- Price erosion through generics and biosimilars.
Risk Factors
- Entry of biosimilars or novel therapies with better safety profiles.
- Changes in reimbursement policies favoring lower-cost alternatives.
- Supply chain disruptions affecting procurement costs.
Summary
NDC 10631-0003 operates within a stable, mature corticosteroid market. Prices are expected to decline gradually, influenced by generic competition and policy pressures. The overall market demand remains steady, driven by widespread clinical use and expanding indications.
Key Takeaways
- The corticosteroid market is growing with rising autoimmune disease prevalence.
- Competition from generics and biosimilars exerts downward pressure on prices.
- Price projections suggest continued declines, with vial prices potentially reaching approximately $2.00 by 2025.
- Market growth sustains demand in outpatient and hospital settings.
- Reimbursement policies and regulatory environment are key factors affecting future pricing.
FAQs
1. How does patent exclusivity influence the price of NDC 10631-0003?
Patent protection maintains higher prices by limiting generic competition. Once patents expire, prices typically decline due to increased generic and biosimilar entries.
2. What are the main competitors of NDC 10631-0003?
Main competitors include methylprednisolone, triamcinolone, and hydrocortisone formulations from various generic and brand manufacturers.
3. How do reimbursement policies impact pharmacoeconomic dynamics?
Reimbursement policies favor lower-cost treatments, which encourages use of generics and biosimilars, leading to price reductions.
4. What are the key factors affecting the supply chain for corticosteroids?
Raw material availability, manufacturing capacity, regulatory approvals, and geopolitical issues influence supply chain stability and pricing.
5. How does biosimilar entry affect market prices?
Biosimilars increase competition, reduce prices, and shift market shares away from branded products, affecting overall market pricing.
Citations
[1] Fortune Business Insights, "Rheumatoid Arthritis Market Size, Share & Industry Analysis." 2022.
